Sean Ellis

Insider Reports History

Entity
Individual
Location
Kiryat Hadassah, Minrav Building, Fifth Floor, Jerusalem, Israel
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean Ellis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entera Bio Ltd. Director Ordinary Shares, par value NIS 0.0000769 per share 135K $135K $1.00 Jan 15, 2025 Direct
Entera Bio Ltd. Director Stock Option (right to buy) 28.5K Jan 15, 2025 Direct

Insider Reports Filed by Sean Ellis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENTX Entera Bio Ltd. Jan 15, 2025 2 $0 4 Jan 17, 2025 Director
ENTX Entera Bio Ltd. Oct 2, 2024 1 $0 4 Oct 4, 2024 Director
ENTX Entera Bio Ltd. Aug 27, 2024 1 $0 4 Aug 29, 2024 Director
ENTX Entera Bio Ltd. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
ENTX Entera Bio Ltd. Aug 21, 2023 1 $24K 4 Aug 22, 2023 Director
ENTX Entera Bio Ltd. Jan 2, 2023 1 $0 4 Jan 4, 2023 Director
ENTX Entera Bio Ltd. Nov 11, 2022 1 $15.9K 4 Nov 14, 2022 Director
ENTX Entera Bio Ltd. Jul 21, 2022 1 $24.4K 4 Jul 25, 2022 Director
ENTX Entera Bio Ltd. Jan 18, 2022 0 $0 4/A Jul 25, 2022 Director
ENTX Entera Bio Ltd. Jan 1, 2022 0 $0 3/A Jul 25, 2022 Director
ENTX Entera Bio Ltd. Jan 1, 2022 2 $0 4 Jan 14, 2022 Director